Market Research Life Sciences Market Research Pharmaceuticals Market Research Manufacturing, Packaging & Detailing Market Research

Cell Culture Market (Product: Instruments, Media, Sera, and Reagents; and End-user: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 212 Pages Transparency Market Research Pvt. Ltd. April, 2022 TNPR17203507
Best Price Guarantee
Price from $5,795
Length 212 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date April, 2022
SKU TNPR17203507

Cell Culture Market (Product: Instruments, Media, Sera, and Reagents; and End-user: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Cell Culture Market – Scope of Report
TMR’s report on the global cell culture market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global cell culture market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell culture market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cell culture market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell culture market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cell culture market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell culture market.

The report delves into the competition landscape of the global cell culture market. Key players operating in the global cell culture market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell culture market profiled in this report.

Key Questions Answered in Cell Culture Market Report
What will be the revenue generated in the cell culture market across all regions during the forecast period?
What are key trends in the cell culture market?
What are major drivers, restraints, and opportunities in the market?
Which region is set to expand at the maximum CAGR during the forecast period?
Which segment of the cell culture will generate the maximum revenue globally by 2028?
Which device segment will expand at the maximum CAGR during the forecast period?
Cell Culture Market – Research Objectives and Research Approach
The comprehensive report on the global cell culture market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cell culture market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell culture market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cell Culture Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Culture Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Top 3 players operating in the market space
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Cell Culture Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product Type, 2017–2031
6.3.1. Instruments
6.3.1.1. Cell Culture Vessels (bioreactor)
6.3.1.2. Carbon Dioxide Incubators
6.3.1.3. Biosafety Cabinets
6.3.1.4. Cryogenic Tanks
6.3.1.5. Others
6.3.2. Media Type
6.3.2.1. Chemically-defined
6.3.2.2. Classical Media
6.3.2.3. Lysogeny Broth (LB)
6.3.2.4. Protein Free
6.3.2.5. Serum Free
6.3.2.6. Specialty Media
6.3.3. Sera
6.3.3.1. Fetal Bovine
6.3.3.2. Newborn Calf
6.3.3.3. Others
6.3.4. Reagents
6.3.4.1. Albumin
6.3.4.2. Amino Acids
6.3.4.3. Attached Factors
6.3.4.4. Growth Factors & Cytokines
6.3.4.5. Protease Inhibitors
6.3.4.6. Thrombin
6.3.4.7. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Cell Culture Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2031
7.3.1. Biotechnology & Pharmaceutical Companies
7.3.2. Academic & Research Institutes
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Cell Culture Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value & Volume Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Cell Culture Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Product Type, 2017–2031
9.2.1. Instruments
9.2.1.1. Cell Culture Vessels (bioreactor)
9.2.1.2. Carbon Dioxide Incubators
9.2.1.3. Biosafety Cabinets
9.2.1.4. Cryogenic Tanks
9.2.1.5. Others
9.2.2. Media Type
9.2.2.1. Chemically-defined
9.2.2.2. Classical Media
9.2.2.3. Lysogeny Broth (LB)
9.2.2.4. Protein Free
9.2.2.5. Serum Free
9.2.2.6. Specialty Media
9.2.3. Sera
9.2.3.1. Fetal Bovine
9.2.3.2. Newborn Calf
9.2.3.3. Others
9.2.4. Reagents
9.2.4.1. Albumin
9.2.4.2. Amino Acids
9.2.4.3. Attached Factors
9.2.4.4. Growth Factors & Cytokines
9.2.4.5. Protease Inhibitors
9.2.4.6. Thrombin
9.2.4.7. Others
9.3. Market Value & Volume Forecast, by End-user, 2017–2031
9.3.1. Biotechnology & Pharmaceutical Companies
9.3.2. Academic & Research Institutes
9.3.3. Others
9.4. Market Value & Volume Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Cell Culture Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2017–2031
10.2.1. Instruments
10.2.1.1. Cell Culture Vessels (Bioreactor)
10.2.1.2. Carbon Dioxide Incubators
10.2.1.3. Biosafety Cabinets
10.2.1.4. Cryogenic Tanks
10.2.1.5. Others
10.2.2. Media Type
10.2.2.1. Chemically-defined
10.2.2.2. Classical Media
10.2.2.3. Lysogeny Broth (LB)
10.2.2.4. Protein Free
10.2.2.5. Serum Free
10.2.2.6. Specialty Media
10.2.3. Sera
10.2.3.1. Fetal Bovine
10.2.3.2. Newborn Calf
10.2.3.3. Others
10.2.4. Reagents
10.2.4.1. Albumin
10.2.4.2. Amino Acids
10.2.4.3. Attached Factors
10.2.4.4. Growth Factors & Cytokines
10.2.4.5. Protease Inhibitors
10.2.4.6. Thrombin
10.2.4.7. Others
10.3. Market Value & Volume Forecast, by End-user, 2017–2031
10.3.1. Biotechnology & Pharmaceutical Companies
10.3.2. Academic & Research Institutes
10.3.3. Others
10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Cell Culture Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2017–2031
11.2.1. Instruments
11.2.1.1. Cell Culture Vessels (bioreactor)
11.2.1.2. Carbon Dioxide Incubators
11.2.1.3. Biosafety Cabinets
11.2.1.4. Cryogenic Tanks
11.2.1.5. Others
11.2.2. Media Type
11.2.2.1. Chemically-defined
11.2.2.2. Classical Media
11.2.2.3. Lysogeny Broth (LB)
11.2.2.4. Protein Free
11.2.2.5. Serum Free
11.2.2.6. Specialty Media
11.2.3. Sera
11.2.3.1. Fetal Bovine
11.2.3.2. Newborn Calf
11.2.3.3. Others
11.2.3.4. Total
11.2.4. Reagents
11.2.4.1. Albumin
11.2.4.2. Amino Acids
11.2.4.3. Attached Factors
11.2.4.4. Growth Factors & Cytokines
11.2.4.5. Protease Inhibitors
11.2.4.6. Thrombin
11.2.4.7. Others
11.3. Market Value & Volume Forecast, by End-user, 2017–2031
11.3.1. Biotechnology & Pharmaceutical Companies
11.3.2. Academic & Research Institutes
11.3.3. Others
11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Cell Culture Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2017–2031
12.2.1. Instruments
12.2.1.1. Cell Culture Vessels (bioreactor)
12.2.1.2. Carbon Dioxide Incubators
12.2.1.3. Biosafety Cabinets
12.2.1.4. Cryogenic Tanks
12.2.1.5. Others
12.2.2. Media Type
12.2.2.1. Chemically-defined
12.2.2.2. Classical Media
12.2.2.3. Lysogeny Broth (LB)
12.2.2.4. Protein Free
12.2.2.5. Serum Free
12.2.2.6. Specialty Media
12.2.3. Sera
12.2.3.1. Fetal Bovine
12.2.3.2. Newborn Calf
12.2.3.3. Others
12.2.4. Reagents
12.2.4.1. Albumin
12.2.4.2. Amino Acids
12.2.4.3. Attached Factors
12.2.4.4. Growth Factors & Cytokines
12.2.4.5. Protease Inhibitors
12.2.4.6. Thrombin
12.2.4.7. Others
12.3. Market Value & Volume Forecast, by End-user, 2017–2031
12.3.1. Biotechnology & Pharmaceutical Companies
12.3.2. Academic & Research Institutes
12.3.3. Others
12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Cell Culture Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2017–2031
13.2.1. Instruments
13.2.1.1. Cell Culture Vessels (bioreactor)
13.2.1.2. Carbon Dioxide Incubators
13.2.1.3. Biosafety Cabinets
13.2.1.4. Cryogenic Tanks
13.2.1.5. Others
13.2.2. Media Type
13.2.2.1. Chemically-defined
13.2.2.2. Classical Media
13.2.2.3. Lysogeny Broth (LB)
13.2.2.4. Protein Free
13.2.2.5. Serum Free
13.2.2.6. Specialty Media
13.2.3. Sera
13.2.3.1. Fetal Bovine
13.2.3.2. Newborn Calf
13.2.3.3. Others
13.2.4. Reagents
13.2.4.1. Albumin
13.2.4.2. Amino Acids
13.2.4.3. Attached Factors
13.2.4.4. Growth Factors & Cytokines
13.2.4.5. Protease Inhibitors
13.2.4.6. Thrombin
13.2.4.7. Others
13.3. Market Value & Volume Forecast, by End-user, 2017–2031
13.3.1. Biotechnology & Pharmaceutical Companies
13.3.2. Academic & Research Institutes
13.3.3. Others
13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Thermo Fisher Scientific, Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Merck KGaA
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Cytiva (Danaher Corporation)
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Becton, Dickinson and Company
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Corning Incorporated
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Eppendorf SE
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. HiMedia Laboratories
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Sartorius AG
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. FUJIFILM Irvine Scientific, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. InvivoGen
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. SeraCare (LGC Clinical Diagnostics, Inc.)
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. Miltenyi Biotec
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview
14.3.13. STEMCELL Technologies, Inc.
14.3.13.1. Company Overview
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Solida Biotech GmbH
14.3.14.1. Company Overview
14.3.14.2. Product Portfolio
14.3.14.3. SWOT Analysis
14.3.14.4. Strategic Overview
14.3.15. Caisson Labs, Inc.
14.3.15.1. Company Overview
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview
14.3.16. Cellexus
14.3.16.1. Company Overview
14.3.16.2. Product Portfolio
14.3.16.3. SWOT Analysis
14.3.16.4. Strategic Overview
14.3.17. Pierre Guerin
14.3.17.1. Company Overview
14.3.17.2. Product Portfolio
14.3.17.3. SWOT Analysis
14.3.17.4. Strategic Overview
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cell Culture Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Culture Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Top 3 players operating in the market space
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Cell Culture Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product Type, 2017–2031
6.3.1. Instruments
6.3.1.1. Cell Culture Vessels (bioreactor)
6.3.1.2. Carbon Dioxide Incubators
6.3.1.3. Biosafety Cabinets
6.3.1.4. Cryogenic Tanks
6.3.1.5. Others
6.3.2. Media Type
6.3.2.1. Chemically-defined
6.3.2.2. Classical Media
6.3.2.3. Lysogeny Broth (LB)
6.3.2.4. Protein Free
6.3.2.5. Serum Free
6.3.2.6. Specialty Media
6.3.3. Sera
6.3.3.1. Fetal Bovine
6.3.3.2. Newborn Calf
6.3.3.3. Others
6.3.4. Reagents
6.3.4.1. Albumin
6.3.4.2. Amino Acids
6.3.4.3. Attached Factors
6.3.4.4. Growth Factors & Cytokines
6.3.4.5. Protease Inhibitors
6.3.4.6. Thrombin
6.3.4.7. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Cell Culture Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2031
7.3.1. Biotechnology & Pharmaceutical Companies
7.3.2. Academic & Research Institutes
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Cell Culture Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value & Volume Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Cell Culture Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Product Type, 2017–2031
9.2.1. Instruments
9.2.1.1. Cell Culture Vessels (bioreactor)
9.2.1.2. Carbon Dioxide Incubators
9.2.1.3. Biosafety Cabinets
9.2.1.4. Cryogenic Tanks
9.2.1.5. Others
9.2.2. Media Type
9.2.2.1. Chemically-defined
9.2.2.2. Classical Media
9.2.2.3. Lysogeny Broth (LB)
9.2.2.4. Protein Free
9.2.2.5. Serum Free
9.2.2.6. Specialty Media
9.2.3. Sera
9.2.3.1. Fetal Bovine
9.2.3.2. Newborn Calf
9.2.3.3. Others
9.2.4. Reagents
9.2.4.1. Albumin
9.2.4.2. Amino Acids
9.2.4.3. Attached Factors
9.2.4.4. Growth Factors & Cytokines
9.2.4.5. Protease Inhibitors
9.2.4.6. Thrombin
9.2.4.7. Others
9.3. Market Value & Volume Forecast, by End-user, 2017–2031
9.3.1. Biotechnology & Pharmaceutical Companies
9.3.2. Academic & Research Institutes
9.3.3. Others
9.4. Market Value & Volume Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Cell Culture Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2017–2031
10.2.1. Instruments
10.2.1.1. Cell Culture Vessels (Bioreactor)
10.2.1.2. Carbon Dioxide Incubators
10.2.1.3. Biosafety Cabinets
10.2.1.4. Cryogenic Tanks
10.2.1.5. Others
10.2.2. Media Type
10.2.2.1. Chemically-defined
10.2.2.2. Classical Media
10.2.2.3. Lysogeny Broth (LB)
10.2.2.4. Protein Free
10.2.2.5. Serum Free
10.2.2.6. Specialty Media
10.2.3. Sera
10.2.3.1. Fetal Bovine
10.2.3.2. Newborn Calf
10.2.3.3. Others
10.2.4. Reagents
10.2.4.1. Albumin
10.2.4.2. Amino Acids
10.2.4.3. Attached Factors
10.2.4.4. Growth Factors & Cytokines
10.2.4.5. Protease Inhibitors
10.2.4.6. Thrombin
10.2.4.7. Others
10.3. Market Value & Volume Forecast, by End-user, 2017–2031
10.3.1. Biotechnology & Pharmaceutical Companies
10.3.2. Academic & Research Institutes
10.3.3. Others
10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Cell Culture Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2017–2031
11.2.1. Instruments
11.2.1.1. Cell Culture Vessels (bioreactor)
11.2.1.2. Carbon Dioxide Incubators
11.2.1.3. Biosafety Cabinets
11.2.1.4. Cryogenic Tanks
11.2.1.5. Others
11.2.2. Media Type
11.2.2.1. Chemically-defined
11.2.2.2. Classical Media
11.2.2.3. Lysogeny Broth (LB)
11.2.2.4. Protein Free
11.2.2.5. Serum Free
11.2.2.6. Specialty Media
11.2.3. Sera
11.2.3.1. Fetal Bovine
11.2.3.2. Newborn Calf
11.2.3.3. Others
11.2.3.4. Total
11.2.4. Reagents
11.2.4.1. Albumin
11.2.4.2. Amino Acids
11.2.4.3. Attached Factors
11.2.4.4. Growth Factors & Cytokines
11.2.4.5. Protease Inhibitors
11.2.4.6. Thrombin
11.2.4.7. Others
11.3. Market Value & Volume Forecast, by End-user, 2017–2031
11.3.1. Biotechnology & Pharmaceutical Companies
11.3.2. Academic & Research Institutes
11.3.3. Others
11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Cell Culture Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2017–2031
12.2.1. Instruments
12.2.1.1. Cell Culture Vessels (bioreactor)
12.2.1.2. Carbon Dioxide Incubators
12.2.1.3. Biosafety Cabinets
12.2.1.4. Cryogenic Tanks
12.2.1.5. Others
12.2.2. Media Type
12.2.2.1. Chemically-defined
12.2.2.2. Classical Media
12.2.2.3. Lysogeny Broth (LB)
12.2.2.4. Protein Free
12.2.2.5. Serum Free
12.2.2.6. Specialty Media
12.2.3. Sera
12.2.3.1. Fetal Bovine
12.2.3.2. Newborn Calf
12.2.3.3. Others
12.2.4. Reagents
12.2.4.1. Albumin
12.2.4.2. Amino Acids
12.2.4.3. Attached Factors
12.2.4.4. Growth Factors & Cytokines
12.2.4.5. Protease Inhibitors
12.2.4.6. Thrombin
12.2.4.7. Others
12.3. Market Value & Volume Forecast, by End-user, 2017–2031
12.3.1. Biotechnology & Pharmaceutical Companies
12.3.2. Academic & Research Institutes
12.3.3. Others
12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Cell Culture Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2017–2031
13.2.1. Instruments
13.2.1.1. Cell Culture Vessels (bioreactor)
13.2.1.2. Carbon Dioxide Incubators
13.2.1.3. Biosafety Cabinets
13.2.1.4. Cryogenic Tanks
13.2.1.5. Others
13.2.2. Media Type
13.2.2.1. Chemically-defined
13.2.2.2. Classical Media
13.2.2.3. Lysogeny Broth (LB)
13.2.2.4. Protein Free
13.2.2.5. Serum Free
13.2.2.6. Specialty Media
13.2.3. Sera
13.2.3.1. Fetal Bovine
13.2.3.2. Newborn Calf
13.2.3.3. Others
13.2.4. Reagents
13.2.4.1. Albumin
13.2.4.2. Amino Acids
13.2.4.3. Attached Factors
13.2.4.4. Growth Factors & Cytokines
13.2.4.5. Protease Inhibitors
13.2.4.6. Thrombin
13.2.4.7. Others
13.3. Market Value & Volume Forecast, by End-user, 2017–2031
13.3.1. Biotechnology & Pharmaceutical Companies
13.3.2. Academic & Research Institutes
13.3.3. Others
13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Thermo Fisher Scientific, Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Merck KGaA
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Cytiva (Danaher Corporation)
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Becton, Dickinson and Company
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Corning Incorporated
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Eppendorf SE
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. HiMedia Laboratories
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Sartorius AG
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. FUJIFILM Irvine Scientific, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. InvivoGen
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. SeraCare (LGC Clinical Diagnostics, Inc.)
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. Miltenyi Biotec
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview
14.3.13. STEMCELL Technologies, Inc.
14.3.13.1. Company Overview
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Solida Biotech GmbH
14.3.14.1. Company Overview
14.3.14.2. Product Portfolio
14.3.14.3. SWOT Analysis
14.3.14.4. Strategic Overview
14.3.15. Caisson Labs, Inc.
14.3.15.1. Company Overview
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview
14.3.16. Cellexus
14.3.16.1. Company Overview
14.3.16.2. Product Portfolio
14.3.16.3. SWOT Analysis
14.3.16.4. Strategic Overview
14.3.17. Pierre Guerin
14.3.17.1. Company Overview
14.3.17.2. Product Portfolio
14.3.17.3. SWOT Analysis
14.3.17.4. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings